- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0049734

About Cellix Bio Private Limited
Data last updated:
Cellix Bio Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 May 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74900TG2014PTC094095. Its GSTIN is 36AAFCC6648A1ZU (Telangana).
The company has an authorised share capital of ₹23.1 Cr and a paid-up capital of ₹22.47 Cr. It is led by directors including Achanna Chowdary Valluri and Mahesh Kandula.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹61,900, a decline of 71% compared to the previous year. For the same year it recorded a net loss of ₹58.52 Lakh and EBITDA of -₹8.72 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 61% over three years and 75% over five years.
Its group structure includes 2 subsidiaries.
The company is associated with 2 brands: Cellix Bio Pharma and Cellix Bio. Court records list 12 cases involving the company, including 5 filed by the company and 7 filed against it; 6 cases are pending. The company has 10 deals on record (6 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹36.49 Cr; the latest was in August 2020. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Eureka Aventis Labs Limited with revenue of ₹65,000.
Cellix Bio Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0049734). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cellixbio.com.
Company details
CIN history
Cellix Bio has one previous CIN (Corporate Identification Number): U74900AP2014PTC094095. The current CIN is U74900TG2014PTC094095, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900TG2014PTC094095 | Current |
| U74900AP2014PTC094095 | Previous |
Recognitions & Rankings of Cellix Bio
Contact details
Cellix Bio Private Limited's registered office is in Hyderabad, Telangana. Its website is cellixbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBc – 08 Ground Floor Block B Indu Fortune Annexe, Phase 13 Kukatpally, Hyderabad, Telangana, India – 500085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cellix Bio Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Cellix Bio operates two associated brands: Cellix Bio Pharma and Cellix Bio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A CDMO specializing in the manufacturing of solid drug formulations. | cellixbiopharma.com | |
| Drug discovery is accelerated by AI platform for diseases. | cellixbio.com |
Financials of Cellix Bio Private Limited
FY 2024 filings availableCellix Bio Private Limited reported revenue of ₹61,900 (down 71% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 75% over five years, including a 71% fall in the latest year. EBITDA rose 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹58.52 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cellix Bio Private Limited, buy the company report.
Board of directors of Cellix Bio Private Limited
Cellix Bio has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Achanna Chowdary Valluri Also directs: Asm Organics Private Limited | Director | 21 May 2014 | 12 Years 6 Months | Current |
| Mahesh Kandula | Director | 01 Oct 2014 | 12 Years 1 Months | Current |
| Subramaniam Apparsundaram Also directs: Cellix Bio Pharma Private Limited, V Clinbio Labs Private Limited | Director | 06 Oct 2017 | 9 Years 1 Months | Current |
| Sridhar Koganti Also directs: Cellix Bio Pharma Private Limited, Avaca Pharma Private Limited, Canis Major Empire Ventures LLP and 3 more | Director | 27 Dec 2023 | 2 Years 10 Months | Current |
Peer comparison
Cellix Bio Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eureka Aventis Labs Limited | ₹65,000 (FY 2025) | Delhi, India | ||||
| Aci Pharma Private Limited | ₹64,244 (FY 2024) | -94.0% | New Delhi, Delhi, India | |||
| R P Wires & Cables Private Limited | ₹63,127 (FY 2025) | -100.0% | Lucknow, Uttar Pradesh, India | |||
| Pushkar Pharmaceuticals Pvt Ltd | ₹63,000 (FY 2024) | 23.0% | Chandigarh, India | |||
| Emsons Pharmaceuticals Pvt Ltd | ₹62,450 (FY 2020) | 13.0% | Kolkata, West Bengal, India | |||
| Cellix Bio Private Limitedthis company | ₹61,900 (FY 2024) | -₹58.52 Lakh | -71.0% | Hyderabad, Telangana, India | ||
| Avaca Pharma Private Limited | ₹61,895 (FY 2024) | 49.0% | Guntur, Andhra Pradesh, India | |||
| Adney Formulations Private Limited | ₹61,000 (FY 2023) | 455.0% | Vasai, Maharashtra, India | |||
| Pharmetro Life Sciences Private Limited | ₹60,824 (FY 2024) | 17.0% | Lucknow, Uttar Pradesh, India | |||
| Nirmaya Laboratories Private Limited | ₹60,199 (FY 2025) | Vadodara, Gujarat, India | ||||
| Modern Fastners Pvt Ltd | ₹60,000 (FY 2025) | Chandigarh, India |
To see the full peer comparison of Cellix Bio Private Limited, buy the company report.
Shareholding
The shareholding of Cellix Bio Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cellix Bio Private Limited, buy the company report.
Deals & funding
Cellix Bio Private Limited has 10 deals on record (6 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹36.49 Cr; the latest was in August 2020.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2020 | Funding round | ₹3.7 Cr | Investors: Total Clarity Inc |
| Dec 2019 | Funding round | ₹7.51 Cr | Investors: 2 individuals |
| Feb 2019 | Funding round | ₹11.02 Cr | Investors: 3 individuals |
| Oct 2018 | Funding round | ₹3.51 Cr | Investors: an individual |
| Jul 2018 | Rights issue | ₹1.7 Cr | Investors: an individual |
To see the full deal history of Cellix Bio Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Cellix Bio Private Limited has 12 court cases on record: 5 filed by Cellix Bio, 7 filed against it. 6 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 0 |
| NCLAT | 4 | 4 | 4 |
| District courts | 3 | 2 | 2 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (COS) | Filed against the company by Patentwire Consultants Private Limited | Pending |
| District court, Hyderabad Central, Telangana | Civil suit | Filed against the company by Patentwire Consultants Private Limited | Disposed |
| NCLT, Hyderabad | Insolvency matter | Filed against the company by Patentwire Consultants Private Limited | Disposed |
| NCLAT, NCLAT Chennai | Company appeal | Filed against the company by an individual | Pending |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by an individual | Pending |
To see the full case history of Cellix Bio Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cellix Bio Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Cellix Bio has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Cellix Bio Pharma Private Limited | U73100TG2020PTC138576 | |
| Avaca Pharma Private Limited | U74999AP2016PTC104239 |
To see the full group structure of Cellix Bio Private Limited, buy the company report.
GST
Cellix Bio has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCC6648A1ZU | Telangana | Active | 26 Jul 2017 |
To see the full GST registrations and return filing status of Cellix Bio Private Limited, buy the company report.
Recent activity
Cellix Bio Private Limited has 10 board changes on record since 2014: 4 appointments and 6 cessations. The latest: Nagendra Naidu Nutanapati ceased to be Company Secretary on 31 May 2024.
1 earlier event is in the company report.
News
Frequently asked questions
Cellix Bio is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 May 2014 (12+ years old) and is registered under CIN U74900TG2014PTC094095.
Cellix Bio has 4 current directors:
- Achanna Chowdary Valluri - Director
- Mahesh Kandula - Director
- Subramaniam Apparsundaram - Director
- Sridhar Koganti - Director
The latest financial statements of Cellix Bio on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Cellix Bio is 36AAFCC6648A1ZU, registered in Telangana.
The CIN (Corporate Identification Number) of Cellix Bio is U74900TG2014PTC094095. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cellix Bio has 12 court cases on record: 5 filed by the company and 7 filed against it. 6 are pending. Most are in the high courts.
Cellix Bio was incorporated on 21 May 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Cellix Bio has 10 deals on record (6 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹36.49 Cr; the latest was in August 2020.
The peers of Cellix Bio by revenue are Eureka Aventis Labs Limited, Aci Pharma Private Limited, R P Wires & Cables Private Limited, Pushkar Pharmaceuticals Pvt Ltd, Emsons Pharmaceuticals Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Nagendra Naidu Nutanapati ceased to be Company Secretary on 31 May 2024. Sridhar Koganti was appointed as Director on 27 Dec 2023. Sridhar Koganti ceased to be Additional Director on 06 Dec 2023. Cellix Bio has 10 board changes on record in total.
Yes, Cellix Bio is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0049734).

